AlphaCentric Advisors »

Jasper Therapeuritc shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $329k 18k 18.81

More positions owned by AlphaCentric Advisors

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Abbvie (ABBV)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Astrazeneca Sponsored Adr (AZN)
Novo-nordisk A S Adr (NVO)
Globus Med Cl A (GMED)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Intuitive Surgical Com New (ISRG)
Lamar Advertising Cl A (LAMR)
Boston Scientific Corporation (BSX)

View all positions for AlphaCentric Advisors

Top funds holding Jasper Therapeuritc

Soleus Capital Management
Velan Capital Investment Management
Carlyle
Qiming U.S. Ventures Management
BlackRock
Braidwell
Vanguard Group
Integral Health Asset Management
Morgan Stanley
Samsara BioCapital
Polar Capital Holdings
Franklin Resources
Rock Springs Capital Management
Kingdon Capital Management
Citadel Advisors

View all funds holding Jasper Therapeuritc